Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

tedizolid

tedizolid
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Sivextro POWDER FOR INJECTION, INTRAVENOUS 200 mg    
Sivextro TABLET, ORAL 200 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

tedizolid (Sivextro)

  • 200 mg powder for injection intravenous Daily
  • 200 mg tablet Daily

linezolid (Zyvox)

  • 2 mg/mL solution intravenous 600 mg BID
  • 600 mg tablet BID

Sivextro is classified as non-formulary, not stocked. Interchange to linezolid.

Reviewed: August 26, 2015 (Sivextro)

Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved